Phase 1 Diabetes Trial AD-123 Safety PK Study
ClinicalTrials.gov Studies
Summary
NIH ClinicalTrials.gov registered a new Phase 1 clinical trial (NCT07538466) on April 20, 2026. The study evaluates the safety and pharmacokinetics of investigational drug AD-123 compared to coadministration of AD-1231 and AD-1232 in patients with Diabetes Mellitus.
What changed
NIH registered a new Phase 1 clinical trial (NCT07538466) to study the safety and pharmacokinetics of investigational drug AD-123 versus coadministration of AD-1231 and AD-1232 in patients with Diabetes Mellitus. The trial is classified as Phase 1 with an estimated start date of April 20, 2026.
Pharmaceutical sponsors and clinical investigators involved in diabetes drug development should be aware of this early-stage trial registration as it may represent a competitive or complementary development program in the diabetes therapeutic space. Patients seeking enrollment in diabetes clinical trials can reference NCT07538466 through ClinicalTrials.gov.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Phase 1 NCT07538466 Kind: PHASE1 Apr 20, 2026
Abstract
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Conditions: Diabetes Mellitus
Interventions: AD-123, AD-1231 and AD-1232
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.